CORT FY 2022 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$402M+9.8% YoY

Gross Profit

$396M98.7% margin

Operating Income

$113M28.0% margin

Net Income

$101M25.2% margin

EPS (Diluted)

$0.87

Cash Flow

Operating Cash Flow

$120M

Free Cash Flow

$120M

Stock-Based Comp.

$42M

Balance Sheet

Total Assets

$583M

Total Liabilities

$82M

Stockholders' Equity

$502M

Cash & Equivalents

$66M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$402M	$366M	+9.8%
Gross Profit	$396M	$361M	+9.9%
Operating Income	$113M	$124M	-9.5%
Net Income	$101M	$113M	-9.9%